Navigation Links
Study links low-frequency hearing to shape of the cochlea
Date:4/25/2008

whispering gallery effect in which soft sounds that travel along curved walls in a large chamber remain loud enough that they can be heard clearly on the opposite side of the room.

When sound waves enter the ear, they strike the eardrum and cause it to vibrate. Tiny bones in the ear amplify and transmit these vibrations to the fluid in the cochlea, creating pressure waves that travel along a narrowing canal in the coiled tube-like organ. The canal is one of two main chambers that are created by an elastic membrane that runs the length of the cochlea. The mechanical properties of this basilar membrane vary from very stiff at the broad, outer end to increasingly flexible toward the inner end as the chambers narrow. The basilar membranes graded properties cause the waves to grow and then die away. Different frequencies peak at different positions along the membrane.

Sensory cells are attached to the basilar membrane and have tufts of tiny hairs called stereocilia that stick up into adjacent structures in the canal. As the basilar membrane moves it tilts the sensory cells, causing the stereocilia to bend. The motion generates electric signals that travel along the auditory nerve to the brain. As a result, the sensory cells near the outer end of the cochlea detect high-pitched sounds, like the notes of a piccolo, while those at the inner end of the spiral detect lower-frequency sounds, like the booming of a bass drum.

This mechanical ordering of response from high to low frequencies works in the same fashion whether the cochlear tube is laid out straight or coiled in a spiral. But Manoussakis calculations predicted that the spiral shape causes the energy in the low-frequency waves to accumulate against the outside edge of the chamber. This uneven energy distribution, in turn, causes the membrane to move more toward the outer wall of the chamber, enhancing the bending of the stereocilia. The enhancement is strongest at the apex of the spiral, whe
'/>"/>

Contact: David F. Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Study begins to reveal clues to the cause and progression of sepsis
4. Clones on task serve greater good, evolutionary study shows
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. New study examines how rearing environment can alter navigation
7. Study links cat disease to flame retardants in furniture and to pet food
8. New continent and species discovered in Atlantic study
9. Study shows link between alcohol consumption and hiv disease progression
10. Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures
11. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... 13, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND ... and secure method to make payments.  With this ... introduced with its groundbreaking voice-direct payment patent application, ...
(Date:7/8/2015)... 8, 2015 Summary Pancreatic cancer is ... most fatal, with a mortality rate of 10.9 deaths ... pancreatic cancer patients has highlighted a significant need for ... being met by the current market. A highly ... with varying molecule types and mechanisms of action, which ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... University and international collaborators have found a way to ... more effective therapy with fewer side effects for potential ... , The studies were carried out in the laboratories ... of Chemistry and the Linda & Jack Gill Chair ...
... The U.S. preterm birth rate dropped for the fifth ... decade, giving thousands more babies a healthy start in life and ... Vermont, Oregon, New Hampshire, and Maine earned an "A" on ... preterm birth rates met the March of Dimes 9.6 percent goal. ...
... Hopkins engineering students won $15,000 in a national competition ... low-tech method that impoverished villagers can use to make ... -- for the design of a machine to convert ... was presented recently in Houston during a ceremony honoring ...
Cached Biology News:Hormone combination effective and safe for treating obesity in mice 2US preterm birth rate shows 5-year improvement 2US preterm birth rate shows 5-year improvement 3Plan to turn farm waste into paper earns students $15,000 2
(Date:7/28/2015)... Research and Markets ... the "Analysis of the Global Flow Cytometry ... Globally, flow cytometry remains a popular tool ... and stem cells. But the market is witnessing ... demand from underdeveloped nations to quantitate CD4 cell ...
(Date:7/28/2015)... -- Deerfield Management Company, L.P. today announced the launch ... invest in groundbreaking advancements in science that may lead ... diseases. The venture capital fund will also back new ... improve the way healthcare is delivered to patients. ... funds in the sector, will donate all profits not ...
(Date:7/28/2015)... N.J. , July 28, 2015  Moerae ... second Phase 1 clinical trial with MMI-0100, a ... is being developed for pulmonary disorders characterized by ... United Kingdom , is a ... further evaluating the safety and tolerability of MMI-0100 ...
(Date:7/28/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... to German life sciences entrepreneurs with a proven ... biotechnology (collectively, the "Optionee"), an option to license ... technology (the "Technology"), including AEZS-120, the most advanced ... to enter a Phase 1 clinical trial. This ...
Breaking Biology Technology:Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3
... March 18 Caliper Life,Sciences, Inc. (Nasdaq: ... the,Lehman Brothers Global Healthcare Conference in Miami, will ... EDT. Kevin Hrusovsky, President and CEO of,Caliper, will ... The live,webcast can be accessed at, http://cc.talkpoint.com/LEHM002/031808a_jw/default.asp?entity=Caliper . ...
... biotech CEOs and,the president of one of the ... Greater Baltimore Committee as winners of the region,s ... Greater Baltimore Region Bioscience Awards are:, -- ... President & CEO, CSA,Medical, Inc. Askew,s very young ...
... 18 LigoCyte Pharmaceuticals,Inc., a vaccine company ... has,successfully finalized an agreement for a $28 ... development of its two lead vaccines,against norovirus ... is being led by Forward Ventures, JAFCO,and ...
Cached Biology Technology:Three CEOs and University President Named Winners of Greater Baltimore Committee's 2008 Baltimore Region Bioscience Awards 2LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round 2LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round 3
IHC detection kit for BrdU in cells and tissues...
Immunogen: Human Respiratory Syncytial Virus (RSV) and Bovine Respiratory Syncytial Virus (BRSV) Fusion protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
Biology Products: